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Abstract
Background  and  objectives: We  investigated  the  effect  of  dexmedetomidine  on  ischemic  renal
failure in  rats.
Methods:  In  the  present  study,  26  male  adult  Wistar  albino  rats  weighting  230--300  g  were
randomly separated  into  four  groups:  sham-operated  (n  =  5),  ischemia  reperfusion  (IR)  (IR
group,  n  =  7),  IR/reperfusion  treatment  with  dexmedetomidine  (Dex.  R  group,  n  =  7)  and  IR/pre-
ischemic  treatment  with  dexmedetomidine  (Dex.  I  group,  n  =  7).  In  the  ﬁrst  group,  sham
operation was  achieved  and  renal  clamps  were  not  applied.  For  the  IR  group,  renal  ischemia
was  induced  by  occlusion  of  the  bilateral  renal  arteries  and  veins  for  60  min  followed  by  reper-
fusion  for  24  h.  For  the  Dex.  R  and  Dex.  I  groups,  the  same  surgical  procedure  as  in  the  IR  group
was  performed,  and  dexmedetomidine  (100  mcg/kg  intraperitoneal)  was  administrated  at  the
5th  min  after  reperfusion  and  before  ischemia.  At  the  end  of  reperfusion,  blood  samples  were
drawn,  the  rats  were  sacriﬁced,  and  the  left  kidney  was  processed  for  histopathology.
Results: The  blood  urea  nitrogen  (BUN)  levels  in  groups  Dex.  R  and  Dex.  I were  signiﬁcantly
lower than  in  the  IR  group  (p  =  0.015,  p  =  0.043),  although  urine  ﬂow  was  signiﬁcantly  higher
in  group  Dex.  R  (p  =  0.003).  The  renal  histopathological  score  in  the  IR  group  was  signiﬁcantly
higher  than  in  the  other  groups.  There  was  no  signiﬁcant  difference  between  the  Dex.  R  and
Dex.  I  groups.
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E-mail: edipgonullu@gmail.com (E. Gonullu).
104-0014      © 2013 Sociedade Brasileira de Anestesiologia. Published by Elsevier Editora Ltda. 
ttp://dx.doi.org/10.1016/j.bjane.2013.06.002
Este é um artigo Open Access sob a licença de CC BY-NC-ND
Dexmedetomidine  in  renal  ischemia  reperfusion  injury  153
Conclusions:  The  results  were  shown  that  administration  of  dexmedetomidine  reduced  the  renal
IR injury  histomorphologically.  Administration  of  dexmedetomidine  in  the  reperfusion  period
was  considered  as  more  effective  due  to  increase  in  urinary  output  and  decrease  in  BUN  levels.
©  2013  Sociedade  Brasileira  de  Anestesiologia.  Published  by  Elsevier  Editora  Ltda.   
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Acut  renal  failure  is  an  acute  ischemic  response  of
the kidneys  occurring  due  to  hypoperfusion  secondary
to hypotension,  hypovolemia  and  dehydration  as  well  as
ischemia/reperfusion (IR)  injury  presenting  with  high  mor-
tality and  morbidity  in  clinical  practice.1--3
Increased  microvascular  permeability,  interstitial
edema, impaired  vasoregulation,  inﬂammatory  cell  inﬁl-
tration, parenchymal  cell  dysfunction,  and  acute  tubular
necrosis (ATN)  have  been  shown  in  the  histopathological
studies related  to  renal  IR  injury.4--6 These  changes  peaked
at the  24th  hours  after  reperfusion  and  they  correlated  with
increased levels  of  blood  urea  nitrogen  (BUN)  and  serum
creatinine (Cr)  which  they  are  used  as  an  indicator  for  renal
function in  clinical  settings.7,8
Dexmedetomidine  is  an  active  dextro-stereoisomer
of medetomidine  and  selective  2-adrenoceptor
agonist.9 Dexmedetomidine  reduces  the  plasma  levels
of catecholamines,10,11 provides  hemodynamic  stabil-
ity during  surgery12,13 and  increases  the  urinary  ﬂow
rate.14 Villela  et  al.15,  and  Frumento  et  al.16 showed  that
dexmedetomidine caused  aqueous  diuresis  by  reducing
central vasopressin  secretion  and  signiﬁcantly  improved
renal functions  postoperatively  in  their  both  clinical  and
experimental studies.  Kocoglu  et  al.17 have  been  studied
the effects  of  dexmedetomidine  on  renal  IR  injury.  They
found improved  histological  scores  at  the  end  of  the  45  min
of reperfusion  following  1  h  of  complete  renal  ischemia.
The  aim  of  this  study  was  to  examine  the  histopathologic
and biochemical  effects  of  dexmedetomidine  administrated
two different  times  (before  ischemia  and  at  the  beginning  of
reperfusion) on  renal  IR  injury  at  24th  hour  of  reperfusion.
Materials and methods
Twenty-six  adult  Wistar  albino  rats  weighing  230--300  g  were
used in  this  study.  The  animals  were  housed  in  a  light  con-
trolled room  with  a  12-h  light/dark  cycle  and  allowed  access
to food  and  water.  Experimental  protocols  and  animal  care
methods in  the  experiment  were  approved  by  the  Experi-
mental Animal  Research  Committee  of  our  institution.
Rats  were  divided  into  four  groups:  sham  operated  group
(n =  5),  IR/untreated  group  (IR  group,  n  =  7),  reperfusion
treatment with  dexmedetomidine  (100  g/kg  at  5  min  after
the reperfusion,  ip)  (Dex.  R  group,  n  =  7),  preischemic  treat-
ment with  dexmedetomidine  (100  g/kg  at  5  min  before
the ischemia,  ip)  (Dex.  I  group,  n  =  7).  The  rats  were
anesthetized with  ketamine  (50  mg/kg  ip)  and  xylazine
hydrochloride (10  mg/kg  ip)  and  bilateral  renal  pedicles
were exposed  after  laparotomy.  After  anesthesia,  the  rats
h
s
gere  heated  with  a  heating  lamp  to  maintain  a  rectal  body
emperature of  37 ◦C.  Isotonic  saline  solution  accounted  of
5% of  rat  body  weight  was  given  intraperitoneally  before
losure of  abdomen.  For  ischemia  and  reperfusion  injury
nduced, bilateral  renal  pedicle  occlusion  was  performed
ith hemostasis  clip  for  60  min.  At  the  end  ischemic  period,
he clips  were  removed  for  blood  reperfusion.  In  sham  oper-
ted group,  bilateral  renal  pedicles  were  exposed  without
ny intervention  after  laparotomy.  The  animals  exposed
o 60  min  ischemia  were  housed  in  metabolic  cages  24  h
fter reperfusion;  24  h  urine  samples  were  collected.  At  the
eginning of  study,  1  ml  of  blood  sample  was  drawn  from
he lateral  tail  vein  for  the  measurement  of  basal  renal
unction parameters  before  abdominal  incision.  At  the  end
f reperfusion,  the  animals  were  anesthetized,  the  blood
amples were  drawn  from  the  right  atrium  for  the  measure-
ent of  renal  function  parameters  and  left  kidneys  were
xcised. The  kidneys  were  ﬁxed  in  10%  buffered  formalin
nd embedded  in  parafﬁn  wax,  cut  at  4--5  m  and  stained
ith hematoxylin  and  eosin  for  histological  studies  using
ight microscope.
Histopathologic changes  were  analyzed  for  mononuclear
ell inﬁltration,  erythrocyte  extravasation,  capillary  dilata-
ion, renal  corpuscle  morphology,  vacuolization  of  proximal
ubules, apoptosis,  loss  of  tubular  brush  border,  tubu-
ar dilatation  and  cast  formation.  Tubulointersititial  injury
as scored  as  follows:  0  =  none,  1  =  0--10%,  2  =  11--25%,
 =  26--45%,  4  =  46--75%,  and  5  =  76--100%.18 The  scoring  of  the
istological data  was  performed  by  blind  investigator.
Blood  urea  nitrogen  and  plasma  Cr  levels  were
easured. Fractional  sodium  excretion  (FANa)  and  Cr  clear-
nce (CCr)  were  calculated  from  the  following  formula:
ANa =  UNaV/(PNa  ×  creatinine  clearance)  ×  100  (UNaV:  uri-
ary sodium,  PNa:  plasma  sodium);19 CCr  =  (Urine  Cr  ×  urine
olume)/(Plasma Cr  ×  time).20
For  statistical  analysis,  SPSS  15.0  (Statistical  Package
or the  Social  Sciences  ver.  15,Chicago,  IL,  USA)  was
sed. All  data  were  expressed  as  mean  ±  standard  devi-
tion (mean  ±  SD).  Univariate  analysis  was  conducted  via
ann--Whitney U  test  to  compare  two  independent  groups.
he level  of  statistical  signiﬁcance  was  accepted  as  p  <  0.05.
esults
 total  of  26  rats  were  included  in  the  study.  One  rat  in  the
R group  died  during  the  ischemia  period  and  was  excluded
rom the  study;  thus,  25  subjects  completed  the  study.  The
istopathological scores  of  the  rats  in  all  groups  are  pre-
ented in  Table  1.
The histomorphologic  injury  scores  of  the  sham  operated
roup were  statistically  signiﬁcant  lower  than  IR,  Dex.  I  and
154  E.  Gonullu  et  al.
Table  1  Histopathologic  scores  in  groups.
Groups  Proximal  tubulus  Mononuclear
cell  inﬁltration
Erythrocyte
extravasation
Sham  operated  (n  =  5)  0.00  ±  0.00  0.20  ±  0.44  0.00  ±  0.00
IR (n  =  6)  2.50  ±  0.55  1.33  ±  0.52  2.17  ±  0.75
Dex. R  (n  =  7)  1.57  ±  0.53  0.86  ±  0.38  1.29  ±  0.49
Dex. I  (n  =  7)  1.71  ±  0.49  1.00  ±  0.58  1.57  ±  0.53
p values
p12 0.003  0.010  0.004
p13 0.002  0.029  0.002
p14 0.002 0.030 0.002
p23 0.018 0.081 0.036
p24 0.026 0.291 0.133
p34 0.591  0.593  0.298
IR, ischemia reperfusion group; Dex R, ischemia reperfusion/reperfusion treatment with dexmedetomidine; Dex I, ischemia reper-
fusion/preischemic treatment with dexmedetomidine. Mann Whitney-U test was conducted to compare two independent groups.
p12: comparison of sham operated and IR.
p13: comparison of sham operated and Dex. R.
p14: comparison of sham operated and Dex. I.
p23: comparison of IR and Dex. R.
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observed.  In  some  areas  in  the  cortex,  vasodilatation  and
erythrocyte extravasation  were  prominent  (Fig.  2A--C).
In  the  Dex.  R  group,  mononuclear  cell  inﬁltration  in
the peritubular  area  and  erythrocyte  extravasation  was
observed less  than  in  the  IR  group.
Tubular  atrophy,  tubular  dilation  and  vacuolization,  pro-
teinaceous material  deposition  in  the  tubules,  and  loss  of
cell debris  and  brush  border  to  tubule  lumen,  which  were
observed in  the  IR  group,  were  observed  less  in  the  Dex.  R
group (Fig.  3A,  Fig.  3B).
In  the  Dex.  I group,  reductions  in  mononuclear  cell
inﬁltration in  the  cortical  region,  especially  in  the  peritubu-
lar area  and  in  degeneration  tubule  cells  and  erythrocyte
extravasation were  observed  compared  to  the  IR  group.
(Fig. 4A,  Fig.  4B).
In the  histomorphologic  comparison  of  the  Dex.  R  and
Dex. I  groups,  the  brush  border  loss  observed  in  proximal
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50,0 µmp24: comparison of IR and Dex. I.
p34: comparison of Dex. R and Dex. I.
ex.  R  groups  (respectively,  p  =  0.003,  p  =  0.002,  p  =  0.002).
he scores  were  signiﬁcantly  higher  in  the  IR  group  than
ex. I  and  Dex.  R  groups  (respectively,  p  =  0.018,  p  =  0.026).
he difference  between  the  scores  of  the  Dex.  R  and  Dex.  I
roups  was  not  statistically  signiﬁcant  (p  =  0.59).
ononuclear  cell  inﬁltration
he  histomorphologic  injury  scores  of  the  sham-control
roup were  signiﬁcantly  lower  than  of  the  IR,  Dex.  I  and
ex. R  groups  (respectively,  p  =  0.01,  p  =  0.029,  p  =  0.03).
he differences  between  the  scores  of  the  IR,  Dex.  I  and
ex. R  groups  were  not  statistically  signiﬁcant  (respectively,
 =  0.08,  p  =  0.29).  The  difference  between  the  scores  of  the
ex. R  and  Dex.  I  groups  was  not  statistically  signiﬁcant
p = 0.59).
rythrocyte  extravasation
he  histomorphologic  injury  scores  of  the  sham-control
roup were  statistically  signiﬁcant  lower  than  IR,  Dex.  I and
ex. R  groups  (respectively,  p  =  0.004,  p  =  0.002,  p  =  0.002).
he scores  of  the  IR  group  were  signiﬁcantly  higher  than  Dex.
 group  (p  =  0.03),  but  there  was  no  statistically  signiﬁcant
ifference between  the  scores  of  the  IR  and  Dex.  I  groups
p = 0.29).
The  sham  operated  group  showed  normal  morphological
eatures. No  cell  inﬁltration  or  loss  of  tubular  brush  border
as observed  (Fig.  1).
For  the  IR  group,  inﬁltration  of  mononuclear  cells  in
he peritubular  area,  especially  the  cortical  area,  brush
order loss  in  the  proximal  tubule  cells,  tubular  atrophy,
ubular dilatation,  and  vacuolization  were  observed.  In
ome tubules,  proteinaceous  material  deposition  with  cast
ormation and  cell  debris  in  the  lumen  of  the  tubule  were
Figure  1  The  sections  of  sham  operated  group.  G:  glomeru-
lus, P:  proximal  tubule,  D:  distal  tubule,  (  )  tubular  brush
border.
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Figure  2  (A)  The  sections  of  ischemia  reperfusion  group.  G:  glomerulus,  P:  proximal  tubule,  D:  distal  tubule,  (  )  the  accumu-
lation of  proteinaceous  material  at  tubules,  ():  proximal  tubule  epithelia  cells  poured  into  the  lumen.  (B)  The  sections  of  ischemia
reperfusion  group.  G:  glomerulus,  P:  proximal  tubule,  D:  distal  tubule,  (  )  mononucleer  cell  inﬁltration,  ():  proximal  tubule
epithelia  cells  poured  into  the  lumen.  (C)  The  sections  of  ischemia  reperfusion  group.  (  )  erythrocyte  extravasation,  ():
tubules and  the  accumulation  of  proteinaceous  material  at  tubules.
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tFigure  3  (A--B)  The  sections  of  reperfusion  treatment  with  d
tubule,  ( )  the  apperence  that  the  accumulation  of  proteina
tubule  cells,  tubular  atrophy,  tubular  dilatation,  vacuoliza-
tion, proteinaceous  material  deposition  in  some  tubules,
cast formation,  and  cell  debris  in  the  lumen  of  tubules  seen
in the  Dex.  I  group  were  observed  less  in  Dex.  R  group.  In  the
statistical analysis  of  the  semiquantitative  light  microscopy
scoring for  these  two  groups,  no  statistically  signiﬁcant
differences were  determined  in  the  scores  of  erythrocyte
extravasation, proximal  tubule  and  mononuclear  cell  inﬁl-
tration.
Biochemical  parameters
For  the  IR  group,  urine  volume  and  CCr  were  signiﬁcantly
lower (respectively,  p  =  0.006,  p  =  0.025)  and  BUN,  blood  Cr
and FANa excretion  levels  were  signiﬁcantly  higher  than  in
the sham-control  group  (respectively,  p  = 0.006,  p  =  0.006,
p =  0.025).Urine  volume  was  signiﬁcantly  higher  in  the  Dex.  R  group
than in  the  IR  and  Dex.  I  groups  (respectively,  p  =  0.003,
p =  0.030)  and  BUN  value  was  signiﬁcantly  lower  in  the  Dex.
R and  Dex.  I  groups  than  in  the  IR  group  (respectively,
s
a
w
50,0 µm 
P
D
G
Figure  4  (A--B)  The  sections  of  preischemic  treatment  with  dexm
tubule,  (  )  proximal  tubule  epithelial  cells  poured  into  the  lumdetomidine  group.  G:glomerulus,  P:proximal  tubule,  D:  distal
 material  at  tubules  reduced  compared  to  other  groups.
 =  0.015,  p  =  0.043).  Biochemical  data  of  the  groups  were
resented in  Table  2.
iscussion
n  this  experimental  study,  a  60-min  rat  renal  IR  model
as used  to  create  a  life-threatening  renal  injury,  which
as induced  by  bilateral  clamping  of  renal  vascular  struc-
ures. Renal  injury  was  examined  according  to  the  changes
n histomorphology  and  renal  function  at  the  24th  hour  of
eperfusion. At  current  study  compared  to  the  sham  oper-
ted group,  as  signs  of  this  impairment  in  renal  function,  a
igniﬁcant decrease  in  UV  and  CCr  and  signiﬁcant  increase
n the  levels  of  FANa,  BUN  and  Cr  were  found  in  IR  group.
In  addition,  the  presence  of  renal  tubular  injury  was
upported by  signiﬁcantly  increased  histopathologic  injury
cores compared  with  the  sham  operated  group.  These  his-
ological and  biochemical  ﬁndings  in  accordance  with  prior
tudies have  shown  that  IR  injury  caused  both  glomerular
nd tubular  dysfunction  in  the  kidney.17,19,21
In  the  previous  studies  in  which  renal  IR  injury  models
ere created,  different  ischemia  and  reperfusion  durations
50,0 µm
D
P
edetomidine  group.  G:glomerulus,  P:proximal  tubule,  D:  distal
en.
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Table  2  Biochemical  data  of  the  groups  at  24th  hour  after  reperfusion;  blood  urea  nitrogen,  blood  creatinine  level,  creatinine
clearance,  urine  volume,  and  fractional  excretion  of  Na+.
Groups  BUN  Cr  CCr  UV  FANa+
Sham  operated  (n  =  5)  21.80  ±  3.42  0.55  ±  0.04  0.64  ±  0.11  7.72  ±  0.66  125.23  ±  28.56
IR (n  =  6)  129.33  ±  11.32  2.98  ±  0.84  0.01  ±  0.02  0.95  ±  1.25  19542.82  ±  27244.54
Dex.R (n  =  7)  113.71  ±  16.46  2.80  ±  1.00  0.05  ±  0.04  5.92  ±  1.69  4735.43  ±  7441.64
Dex.I (n  =  7)  92.00  ±  43.23  2.35  ±  1.23  0.17  ±  0.19  2.9  ±  2.44  943.28  ±  1378.02
p values
p12 0.004  0.004  0.036  0.004  0.036
p13 0.003  0.003  0.003  0.073  0.030
p14 0.003 0.003 0.008  0.003  0.032
p23 0.014 0.628 0.267 0.001  0.267
p24 0.051 0.445 0.143 0.138 0.071
p34 0.805  0.620  0.432  0.026  0.268
IR, ischemia reperfusion group; Dex R, ischemia reperfusion/reperfusion treatment with dexmedetomidine; Dex I, ischemia reper-
fusion/preischemic treatment with dexmedetomidine; BUN, blood urea nitrogen; Cr, blood creatinine level, CCr, creatinine clearance;
UV, urine volume; FANa+, fractional excretion of Na+.
Mann  Whitney-U test was conducted to compare two independent groups.
p12: comparison of sham operated and IR
p13: comparison of sham operated and Dex. R
p14: comparison of sham operated and Dex. I
p23: comparison of IR and Dex. R
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vp24: comparison of IR and Dex. I
p34: comparison of Dex. R and Dex. I
ere  applied.7,17,19,20,22 Williams  et  al.7 created  ischemia  for
5 min  with  application  of  clips  at  the  bilateral  renal  arteries
nd veins  and  investigated  the  effects  of  IR  injury  on  blood
UN and  Cr  levels  and  renal  histology,  at  reperfusion  for  0,
.5, 1,  2,  4,  6,  9,  and  24  h  and  after  1  week.  These  investiga-
ors reported  that  the  earliest  renal  injury  started  at  the  4th
 following  ischemia  for  45  min  and  peaked  at  the  24th  hour.
imilarly, Yamamoto  et  al.23 and  Arendshorst  et  al.24 showed
hat ATN  and  medullary  perfusion  defect  became  more  man-
fest after  22--48  h  of  reperfusion.  Gu  et  al.22 created  a
oderate renal  damage  with  application  of  clips  on  bilateral
enal pedicles  for  25  min.  For  a  life-threatening  renal  injury
n rats,  they  performed  that  clip  application  on  the  right
enal pedicle  for  40  min,  harvesting  the  left  kidney.  These
esearchers showed  that  plasma  mean  Cr  and  urea  levels
ncreased more  than  7  times  at  the  24th  hour  of  reperfusion
ollowing ischemia  for  40  min.  Kocoglu  et  al.17 documented
istological data  of  reperfusion  injury  for  45  min  following
0-min ischemia  on  the  left  kidney  of  rats  subjected  to
ight kidney  nephrectomy.  In  our  study,  a  60-min  ischemia
odel was  created  with  application  of  clips  on  bilateral
enal pedicles,  and  the  effects  of  IR  and  dexmedetomi-
ine treatments  were  studied  24  hours  after  reperfusion.
cute renal  failure  due  to  ischemia  is  a  complex  syndrome
nvolving renal  vasoconstriction,  tubular  damage,  tubular
ell necrosis,  glomerular  ﬁltration  failure,  and  glomerular
amage.25,26 The  medications  that  may  be  effective  on  the
arious factors  that  contribute  to  this  damage  have  been
sed in  prophylaxis  and  treatment.  Sympathetic  activation
ue to  presynaptic  release  of  noradrenaline  and  increase  in
oradrenaline levels  in  the  circulation  induced  by  stress  in
he kidney,  and  accordingly,  reduction  in  renal  blood  ﬂow
nd glomerular  ﬁltration,  has  been  suggested  as  one  of  the
ossible mechanisms  of  acute  renal  failure  produced  by  IR
njury.
b
a
t
eDexmedetomidine  is  a  selective  and  potent  2-
drenoceptor agonist.  Dexmedetomidine  has  been  reported
o have  effective  protective  efﬁcacy  on  focal  ischemia
n rabbits,  and  cardiac  ischemia,  reperfusion  injury,  and
ncomplete forebrain  ischemia  in  rats.27--29 The  precise
echanism of  the  protective  effect  of  2-adrenergic
gonists in  the  brain  is  unclear.  Catecholaminergic  neuro-
ransmission is  considered  to  possibly  be  related  to  this
ffect. Dexmedetomidine  reduces  excessive  secretion  of
oradrenaline due  to  ischemia  by  activating  presynaptic
2-adrenoceptor.  This  prevents  excessive  noradrenaline
etabolism, which  causes  the  formation  of  free  radicals.  It
s suggested  that  protection  in  brain  injury  provided  with
2O2 production  decreases  in  reperfusion  due  to  prevention
f oxidative  deamination  of  catecholamines.30,31 In  addi-
ion, dexmedetomidine  is  considered  to  cause  reduction  in
ecrotic cell  death  by  decreased  sympathetic  tone,  as  well
s inhibition  of  ion  ﬂow  mediated  by  N-methyl-d-aspartate
eceptor.32 In  addition  to  these  possible  mechanisms,
ngelhard et  al.32 reported  that  dexmedetomidine  caused
n increase  in  the  concentration  of  antiapoptotic  proteins.
n another  study,  Wijeysundera  et  al.33 suggested  that
2-adrenergic  agonists  reduced  mortality  and  myocardial
nfarction in  vascular  surgery.  In  the  earlier  studies,  the
nti-ischemic effect  of  dexmedetomidine  was  demon-
trated to  occur  in  high-dose  administration,  as  100  g/kg;
herefore, in  our  study,  100  g/kg  dose  of  dexmedetomidine
as used  for  renal  IR  injury.17,27,34
Kocoglu  et  al.17 reported  that  dexmedetomidine  dose  of
00 g/kg  i.p.  administered  at  the  start  of  reperfusion  pre-
ents the  injury  produced  by  60-min  ischemia  and  followed
y reperfusion  of  45  min,  which  caused  acute  renal  failure,
nd they  showed  normal  glomeruli  and  a  slight  edema  of
ubular cells.  In  our  study,  different  from  that  of  Kocoglu
t al.17,  dexmedetomidine  was  used  at  two  different  times:
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TDexmedetomidine  in  renal  ischemia  reperfusion  injury  
at  the  beginning  of  reperfusion  and  before  ischemia.  Addi-
tionally, whether  the  renoprotective  effect  continued  until
the 24th  hour  when  IR  injury  peaked,  was  evaluated  by  using
histopathological examination  and  renal  function  tests.  Our
study has  shown  that  mononuclear  cell  inﬁltration,  brush
border loss  of  proximal  tubule  cells,  tubular  atrophy,  tubular
dilatation, vacuolization,  protein  and  cell  debris  accumula-
tion in  some  tubules,  and  erythrocyte  extravasation  were
seen in  the  IR  group.  We  also  showed  that  proximal  tubule
changes, which  were  seen  in  the  IR  group,  decreased  sig-
niﬁcantly in  both  groups  treated  with  dexmedetomidine,
and further,  erythrocyte  extravasation  changes  decreased
signiﬁcantly in  the  group  administered  dexmedetomidine  in
the reperfusion  period.  These  histologic  ﬁndings  have  shown
that, dexmedetomidine  had  a  partial  renoprotective  effect
in both  groups  in  the  24th  hour  of  reperfusion.
Gu  et  al.22 investigated  the  effects  of  dexmedetomidine
in both  human  cell  cultures  as  in  vitro  and  with  rats  as
in vivo  studies.  Their  in  vitro  studies  demonstrated  that
dexmedetomidine provided  protection  of  tubular  structure
and prevention  of  cell  death  with  activation  of  the  Akt
pathway and  weakening  of  the  HMGB1/TLR4  pathway  medi-
ated by  2- adrenergic  receptor.  They  demonstrated  in
their in  vivo  studies  with  rats  that  the  administration  of
dexmedetomidine at  a  dose  of  25  g/kg  i.p.  before  ischemia
caused a  signiﬁcant  reduction  in  the  levels  of  urea,  and  Cr
increased at  the  24th  hour,  due  to  the  effect  of  ischemia
produced by  a  25-min  application  of  clips  to  bilateral  renal
pedicles. The  investigators  also  showed  a  reduction  in  his-
tological damage  scores,  at  53%  and  38%,  respectively,  with
pre- and  post-ischemic  dexmedetomidine.  Again,  in  that
same study,  it  was  reported  that  renal  function  deterio-
ration produced  by  ischemia  for  40  min,  which  was  more
serious (seven  fold  at  24th  hour  after  IR  injury),  signiﬁcantly
decreased with  both  pre-  and  post-ischemic  treatment  and
this effect  was  dependent  on  2 adrenoreceptor.  In  our
study, similarly  with  the  results  of  Gu  et  al.22,  we  found
that renal  histology  and  function  (for  only  BUN  levels)
improved signiﬁcantly  with  dexmedetomidine  used  pre-  and
post-ischemia in  more  severe  IR  injury.  Furthermore,  Cur-
tis et  al.35 studied  the  effects  of  dexmedetomidine  on  renal
histological changes  and  blood  Cr  level  after  IR  injury  in  rats
anesthetized with  ketamin.  These  investigators,  different
from us,  administered  an  2-adrenoceptor  agonist  dose  of
1 g/kg  intravenous  (i.v.)  for  10  min  and  continued  with  a
dose of  1  g/kg/h.  In  that  study,  ischemia  time  was  45  min,
and nephrectomy  and  blood  sampling  were  performed  48  h
after reperfusion.
In accordance  with  our  and  Gu  et  al.22 studies,  they  also
demonstrated that  dexmedetomidine  protected  the  kidneys
partially against  IR  injury  at  late  period  of  reperfusion.
In  their  experimental  study,  Villela  et  al.15 reported  that,
followed by  administration  of  low  dose  dexmedetomidine
(1 and  2  g/kg  bolus  dose  application  followed  by  1  and
2 g/kg,  1-h  i.v.  infusion)  to  the  dogs  under  anesthesia
caused free  water  diuresis  with  decrease  in  urine  osmolality
and plasma  vasopressin  levels.  Frumento  et  al.16 demon-
strated improvement  in  postoperative  renal  function  with
infusion of  dexmedetomidine  in  patients  without  renal  dis-
ease who  underwent  thoracic  surgery,  by  using  glomerular
ﬁltration indicators  involving  urine  ﬂow,  serum  Cr  and  frac-
tional changes  of  serum  Cr  level.  In  that  study,  decrease  in
R157
erum  Cr  levels  peaked  in  the  ﬁrst  postoperative  week.  The
ecrease of  Cr  levels  identiﬁed  in  the  period  of  without  drug
dministration was  accepted  as  proof  of  the  beneﬁcial  effect
f the  drug  on  glomerular  ﬁltration.  According  to  Frumento
t al.16,  the  improvement  in  renal  function  was  related  with
ecreased renal  vasoconstriction  by  dexmedetomidine.  In
ur study,  different  from  these  investigators,  we  determined
imited recovery  in  biochemical  renal  parameters  in  IR
njury. In  this  study,  in  both  groups  administered  dexmedeto-
idine, BUN  values  were  determined  to  be  signiﬁcantly
ower than  in  the  IR  group.  In  addition,  administration  of
exmedetomidine at  the  5th  min  of  reperfusion  provided  a
igniﬁcant increase  in  uriner  output.  However,  this  improve-
ent determined  in  diuresis  and  BUN  levels  could  not  be
hown in  blood  Cr  levels  and  CCr,  which  are  more  spe-
iﬁc, tests  for  the  kidney.  The  results  of  our  study  suggest
hat, a  partial  histomorphological  and  a functional  pro-
ection were  obtained  with  dexmedetomidine  in  renal  IR
njury.
In the  present  study,  Ketamine--Xylazine  (KX)  was  used  as
he anesthetic  regimen  which  was  appropriate  for  ischemia-
eperfusion studies.  As  ketamine  is  compatible  with  the
ther medications  and  has  a  wide  conﬁdence  interval,  it  is
ne of  the  anesthetic  drugs  with  the  widest  usage  range  in
xperimental studies.  Previous  studies  in  the  medical  lit-
rature had  conﬂicting  results  on  the  effect  of  ketamine
n renal  IR  injury.35--38 These  studies  in  the  literature  that
ompare different  anesthetics  lack  a  true  control  group.
imilarly, one  limitation  to  our  study  is  lack  of  a true  con-
rol (no  anesthetic  drug)  group,  as  all  animals  received  KX
s the  anesthetic  regimen  in  accordance  with  our  institu-
ional ethics  committee.  Therefore  we  could  not  determine
he extent  of  protection  induced  by  the  KX  anesthesia  com-
ared with  a  ‘no-drug’  group.  In  order  to  standardize  the
ffect of  anesthetic  regimen  in  our  study,  the  anesthesia
as provided  by  KX  in  all  the  groups.  In  addition;  there
ere sham  and  control  (IR)  groups  in  our  study  and  when
e evaluated  the  results  of  these  groups,  in  which  no  active
aterial was  used  apart  from  the  KX  anesthesia,  renal  I/R
njury was  not  observed  in  the  sham  group  but  occurred  in
he control  group.  Therefore,  we  are  convinced  that  the
esults we  obtained  were  independent  from  the  effect  of  KX
nesthesia.
In  conclusion,  dexmedetomidine  used  both  before
schemia and  after  reperfusion  reduced  the  effects  of  renal
R injury  at  the  24th  hour  histomorphologically.  Although
o histomorphologic  signiﬁcant  difference  was  determined
etween the  two  methods,  administration  of  dexmedetomi-
ine in  the  reperfusion  period  was  considered  more  effective
ue to  the  decrease  in  BUN  levels  and  increase  in  urinary
utput.
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